Please note that this will be a remote presentation
- Why is long acting injectable formulation relevant from a clinical perspective?
- Pharmacokinetic and physical chemical considerations when initiating a formulation program for a long acting injectible product
- Formulation strategies available for long acting injecting release – including some examples
Rene Holm, Head and Scientific Director, Liquids & Parenterals, Janssen